Luspatercept News
Luspatercept currently has 0 news articles, with 10 predicted indications.
This page combines the AI-predicted indications for Luspatercept with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Reblozyl is indicated in adults for the treatment of transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (MDS).Reblozyl is indicated in adults for the...
- Evidence level: L5
- Predicted indications (10):
- monosomy X (96.0%)
- hepatic infarction (95.7%)
- hepatic veno-occlusive disease (94.9%)
- peliosis hepatis (94.8%)
- syndrome with combined immunodeficiency (94.3%)
- pyruvate kinase deficiency of red cells (93.8%)
- thalassemia, beta+, silent allele (93.3%)
- familial apolipoprotein C-II deficiency (93.0%)
- adenosine deaminase deficiency (92.9%)
- Hb Bart's hydrops fetalis (92.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.